Hematology

r

1:48

others

Leukorythroblastic reaction

r

early prematures nucleated RBc and WBC

etiologies

BM infiltraion

r

by turmors so it releases early cell linescan see teardrop RBC as well

BM failure

r

RBC then will be formed in other organs like spleen and liver such as in thelasemia.

spleenectomy

r

like in SSD

Dx

nucleated RBC

primitive WBC

tear drop RBC

Tumor lysis syn.

r

post chemo or spontaneus, specially in Borkette's lymphoma

presentaion

Arrythmia

ARF

lytes abnormailties

Ca/Po4

r

precipitation occur if Ca/PO4 > 60phosphate rises firstHypocalcemia is next.

prevention

urine ph

r

keep neutral.acid urine: prevents Ca/Po4 crystalsAlkaline urine: prevents uric acid crystals

tx sympt. hypocalcemia

Hydration and Allopurinol

Neonatal purpura fulminans

sepsis

prot S or C homozygous

r

need plasma exchange.

Onc

Leukemia

ALL

presentation

Lab

r

initial w/u should include CBC, LDH, Uric acid and ESR

CBC

anemia, thrombocytopenia

pancytopenia

normal

WBC

r

+/- lymphoblasts

normal 1/3

High 1/3

Low 1/3

smear

blasts

r

atypical lymphocytes can mimic blasts: seen in viral infectionsneed manual diff and smear to differentiate both

Organomegaly

2/3

Bone pain

r

can mimic grwoth pain and responds well to steroids as well; however this results in selecting steroids resistant leukemic cellson xray :new leukemic lines over the metaphisis

Rehumtoid like dis. responding to steroid

prognosis

high risk

cytometry

r

Pre B is the most common and best prognosisT cell is more common in older pts.

polidy: DNA index

Philadelphia chrmosome

B cell: borkette

BM post induction

2

r

M2: refractory leukemia. failed to induce remission even after multiple chemo

3

r

M3: blasts > 25% after the first induction. clears after multiple induction

Age

< 1 or > 10

WBC at diagnosis

> 10000

treatment

medical

Chemo

Induction

r

3 weekly cycles ( vincristine x 4Ds, Dounurubicin X 4 ds, Aspargene x 1d) plus daily steroids.Then BM should be cleared.

consolidation

r

3-6 msCNS sanctuary

maintenance

r

30 ms. daily MP6 + weekly MTX + monthly vincristine/solumedrol

CNS chemo

r

Intrathically: first one is rubinoside then MTX after. Repeat x18 over 2 yrs.

PCP prophlyxis

bactrim

r

3 ds/week

Dapsone

r

if allergic to bactrim

BMT

r

as last resort after multiple failure

special types

Leukemia lymphoma syn

r

agressive T cell leukemia

presentaion

CBC

hg and platelets normal

WBC > 100000

massive lymphdenopathy and HSM

mediastinal mass

Prognosis

high risk

recurrence

r

testicular recurrence

AML

r

also know as ANLL: acute non lymphocytic leukemia

presentaion

Hyperviscosity syn

r

WBC > 100000especially in M5

headache

blurry vision

respiratory distress

Infiltration

r

common in type M4 and M5 , the monocyte tumor b/o monocyte existence on tissures

CNS

skin and bones

r

usually facial bones

gum hypertrophy

dx

CBC

auer bodies

r

in M1 and 2 and 3distinguish primitive WBC from sepsis vs AML

leukoerythroblastic reaction

l

DIC

r

in M3 specially after chemoneed pre treatment with Retnoic acid which matures the PreWBC to neurophiles

special types

congenital leukemia

r

presents in the first month. HSM, infiltration and WBC > 100000

CML

dx

CBC

Neutrophilia

basophilia

thromobytosis

Low LAP

r

leukocyte alkaline phosphates LAP: can differentiate between leukocytosis from CML vs sepsis or Leukomoid reaction; latter seen in Down syn,

Incre. B12

BM

r

philadelphia chromosome

phases

r

slowly turns into AML

chronic phase

r

2 yrs. w/o chemo; 4 yrs with chemo

accelarated phase

Blast crisis

r

the terminal phase: massive HSM and lymphadenopathy, anemia and thrombocytopenia

tx

BMT

r

because it's stem cell disease.

chemo

hydroxyurea

Busulfan

interferon

Burkitt's lymphoma

presentation

Abd mass

intessusception

Inguinal lymphadenopathy

r

gerneralized lymphadenopathy in the leukemia/ lymphoma typecervical lymphadenopathy in the african type

Tumor lysis

Lymphoma

presentaion

lymphdenopathy

r

above the diaphragm, in contrast to Burkett's. specially the supraclavivular node whick is always considered pathologic mostly T cells.

immunodefciency

cyclic fever

prognosis

labs

ESR

Cu

Secondary malignancy

AML

breast ca

MDS

r

pre leukemic

lab

pancytopenia

dimorphic RBC

dec. retic.

large plts

Solid tumors

Neuroblastoma

presentaion

legs pain

periorbital ecchymoses

Opsoclonus

catecholamines

HTN

Diarrhea

blasts on peripheral smear

prognosis

ferritin

< 1 yr. good

spontaneus recovery

wilm's

r

IVP or CT shows distorion of the kidney calicyles unlike neuroblastoma which showes displacement.

Prog

associated syn

aniridia

hemihypertrophy

NF

Beckwith Wiedman syn

Retinoblastoma

diff

congenital glucoma

presentaion

glucoma

r

photophobia in neonate and tearing.

strabismus and impaired vision

prog

25 % b/l

secondary tumor: osteogenic sarcoma

osteogenic sarcoma

presentation

painless lesion in distal bone

60% at the knee

pathologic fx

high ALphosphatase

Ewing sarcoma

presentaion

painful mass in mid bone

systemic inflammatory

coagulation dis.

Von Welliberand

r

produced from the endotheliumconnects the plts to the endotheliumbleeding immediatelycarries prot 8. so will results in secondarty low prot VIIIsuperficially bleeding: i.e bleeding into skin and mucosa

dx

r

Blood type O have low normal level of VW

quantity

VWF titers.

Immuno electropheresis

Multimer analysis

Factor VIII

r

usually low if VWF is low. because VWF is carrier prot for factor 8

prolonged PTT

low factor VIII level

quality

r

in VWF type 2 which is mainly malfunction of the factor

Ristocetin co factor

r

testing the function of vwf

Plt functin tests

Ristocetin induced plt aggregation

with epinephrine and collagen

r

this replaced the old fasioned bleeding time but is more reliable.

confirrmation

DDAVP stimulation

r

repeating the tests above before and after DDAVP stimulation

tx

DDAVP

r

release v.w.f from endothelium but with limited quantities.good for chronic txcan cause depletion of V.W.F in rare types of the diesease. type 2 bcan be given q 48 hrs; to allow regeneration of VWF stores.

nasal DDAVP

r

can be given after head trauma prophylactically.

EACA

r

Amicar: aminocabroic acid adjunct to DDAVP in the acute bleeding or for shrot period after surgery, 1 week.

factor replacement

r

concentrates are contrandicates b/o they have factor 8 but not V.W.F

cryopreipitate

FFP

1- clot

r

plts connected to the endothelium through V.W.F forming plt clot,superficial bleeding

plt dysfuncion

congenital

plt aggregation

Glanzman

r

deficiency plt glycoprotein IIbb/IIIa

imapired plt adhesion to V.W.F

Bernard Soulier

r

dx

large plt

impaired adhesion in presen V.W.F

etio

deficiency in plt glycoprot Ib

acquired

Uremia

Myeloproliferative dis

NSAID

low plts

congenital

acquired

auto immune

ITP

without BM aspiration

Winrho

r

for Rh+ positive onlyworks by overloading the spleen with RBC causing hemolysis so it preserves the pltscauses hemoglubinurea from the hemolysis

IVIG

with BM aspiration

Steroid

r

steroid is contradicted without BM aspiration because if it was due to leukemia it causes partial treatment and subsequent resistence.the effect is slower than IvIG

plt transfusion

r

stops the bleeding but does not increase the number

splenectomy

r

for chronic ITP

connective tissue dis

immunodeficiency

AIDS

Congenital

drugs

Heparin

r

can evolve into DICeven from heparin for lines patency

neonatal

r

autoimmune destruction like R.H dis. from different maternal -baby genes

trapping

hypersplenism

micro angiopathic dis.

DIC

HUS

vascular

HUS

Hemangiomas

r

Kasabach-meritt syn

dec. production

congenital infection

transient myelodysplasia

r

mostly in down syn.

BM failure syn

Fanconi anemia

r

is insidious , unlike aplastic anemia which is acute.25% don't have the dysmorphic features; the triphalangeal thmbs.

Dx

clinical

r

insidious; unlike the acute presentation of aplastic anemia75 % have the charachteristic thumb

lab

r

Dx: DNA breakage test, clastogenic assay DAB

Tx

r

BM transplant

T.A.R

r

thrombocytopenia + absent radius

Wiskott aldrich

r

T cell immuno deficiency

2- clot

r

coagulation clotFibrinogen turned into Fibrin with the enzyme thrombindeep bleeding

tx

factor concentrates

cryoprecipitate

r

factor 8 only

DDAVP

EACA

Topical thromin

r

local bleeding, like from a tooth,

thrombophilia

test

prot c

prot c activity

prot s

free total

factor V lyden

activated prot C resistance

factor V mutation

anemia

Iron def.

tx

r

Fe: until Ferritin normailze.Reticulocytosis in 3-7 dsInc. Hg in 2-3 w and normailze in 1 m,avoid tea and soda with meal as it prevents absorptionFe in multivitamin is not sufficient. need 3-6 mg/k and for adult 325 tid.

dx

r

treat empirically without further tests.if no responce to treatment, consider thalasemia trait and do electropherisi

aplastic anemia

dx

acute

lab

r

clastogenic assay to differentiate from fanconi anemia.

tx

BMT

chemo

r

Cyclosporine

SC

SCD

tx

transfusion

r

preferred leukofiltered to reduce allergic reaction

exchange transfusion

r

for acute crisis or chronically post the attack : CVA, chest crisis..

acute

hydroxyurea

r

inc. hg F and so protects from cirisis

clinincal

aplastic crisis

trait

diluted urine

thalmsemia

minor

dx

r

presents like iron deficiency with microcytic anemia but it does not response to Fe. also has inc. reticulocytes unlike Fe anemiaElectropherisis: > 3% A2

major

dx

r

anemia with massive hepatosplenomaegalygenetic tests

PNH

dx

flow cytometry

r

CD55: decay accelerating factor DAFCD59 homologous restriction factor HRFolder tests as sucrose hemolysis and HAM tests are abandoned

tx

steroid

androgen

present

r

changes into aplastic anemia

hemolysis

thrombosis

Auto Hemolysis

lab

direct coombs

r

tests the antibodies attached to the RBC: adds antibodies for the antibodies--> agglutination if pos.

indirect coombs

r

measures the antibodies in the serum.

tx

warm antibod.

steroid

immunosuppresion

IVIG

cold antibod.

poor tx